Research & Reviews: A Journal of Pharmaceutical Science

ISSN: 2229-7006

Editors Overview

rrjops maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Annexins as potential targets in ocular diseases Strabismus

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Ca2+/phospholipid-binding proteins known as annexins (AnxAs) have undergone substantial research and are typically involved in several disorders. Although there is evidence for the distribution of AnxAs in the visual system, it is unclear exactly what these proteins do or which types of eye cells express these proteins. Lexus is a key target in maintaining the homeostasis of the ocular tissue due to its pro-resolving functions in autoimmune, fibrotic, degenerative, viral, and angiogenic diseases. The important discoveries about the distribution and role of annexins in the eye’s normal and diseased states are highlighted in this overview. They are appealing therapeutic candidates for the management of human strabismus illness due to their capacity to affect inflammatory responses.


Annexins, Inflammation, Angiogenesis, Eye retina, Therapeutic target

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: